Ignite Creation Date:
2024-05-05 @ 4:54 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00343512
Status:
TERMINATED
Last Update Posted:
2012-04-27
First Post:
2006-06-22
Brief Title:
Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer
Sponsor:
Vanderbilt-Ingram Cancer Center
Organization:
Vanderbilt-Ingram Cancer Center
Organization Data
Organization:
Vanderbilt-Ingram Cancer Center
Class:
OTHER
Study ID:
VICC BRE 0368
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Vanderbilt-Ingram Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
Bapsi Chak MD
Responsible Party Title:
Associate Professor Radiation Oncologist
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Vanderbilt-Ingram Cancer Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |